ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions at Sionna Therapeutics, Inc. (SION) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Nov 26, 2025, ORBIMED ADVISORS LLC's relationship to Sionna Therapeutics, Inc. (SION) is Director, and currently has 3,596,886 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SION insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions of SION Common Stock

ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions at SION

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 27, 2025	Sell -- (Common Stock)	1600	44.49	3596886
Nov 26, 2025	Sell -- (Common Stock)	11890	44.6	3598486
Nov 25, 2025	Sell -- (Common Stock)	94583	44.54	3610376